Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Betta Pharmaceuticals Co., Ltd.
  6. News
  7. Summary
    300558   CNE100002DD9

BETTA PHARMACEUTICALS CO., LTD.

(300558)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Market Chatter: Chinese Bubble Tea Chain Operator Nayuki Set for Hong Kong Listing Hearing Tomorrow

06/01/2021 | 10:17pm EDT


© MT Newswires 2021
All news about BETTA PHARMACEUTICALS CO., LTD.
09/17Hangzhou Neoantigen Biotechnology co., LTD. announced that it has received $3.1 million..
CI
08/09Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 3..
CI
08/03MARKET CHATTER : JL Mag Rare-Earth Files for $200 Million Hong Kong IPO; Shares Jump 3%
MT
06/22MARKET CHATTER : China Tourism Group to File for Hong Kong IPO This Week
MT
06/08MARKET CHATTER : Chaoju Eye Care Set for Hong Kong Listing Hearing This Week
MT
06/08MARKET CHATTER : China Tourism Group Eyes Secondary Listing in Hong Kong to Raise $10 Bill..
MT
06/06MARKET CHATTER : Chinese Bubble Tea Chain Operator Nayuki Passes Hong Kong Listing Hearing
MT
06/01MARKET CHATTER : Chinese Bubble Tea Chain Operator Nayuki Set for Hong Kong Listing Hearin..
MT
05/25MARKET CHATTER : Betta Pharmaceuticals Set for Hong Kong Listing Hearing This Week
MT
04/28Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended Ma..
CI
More news
Financials
Sales 2021 2 495 M 390 M 390 M
Net income 2021 491 M 76,8 M 76,8 M
Net cash 2021 1 332 M 208 M 208 M
P/E ratio 2021 70,1x
Yield 2021 0,36%
Capitalization 34 460 M 5 390 M 5 391 M
EV / Sales 2021 13,3x
EV / Sales 2022 9,36x
Nbr of Employees 1 600
Free-Float 48,1%
Chart BETTA PHARMACEUTICALS CO., LTD.
Duration : Period :
Betta Pharmaceuticals Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BETTA PHARMACEUTICALS CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 83,04 CNY
Average target price 138,81 CNY
Spread / Average Target 67,2%
EPS Revisions
Managers and Directors
Lie Ming Ding Chairman, Co-Chief Executive Officer & GM
Jia Tong Co-Chief Executive Officer & Director
Jian Xun Fan Chief Financial Officer, Director & Vice President
Yang Nan Zhang Chairman-Supervisory Board
Jiang Wan Chief Operating Officer, Executive Director & SVP
Sector and Competitors